Laboratory of Biological Oxidations, Department of Biochemistry, University of Maringá, 87020900 Maringá, Brazil.
Metabolism. 2011 Oct;60(10):1433-41. doi: 10.1016/j.metabol.2011.02.011. Epub 2011 Apr 12.
The purpose of this work was to evaluate if the fat liver accumulation interferes with intracellular calcium fluxes and the liver glycogenolytic response to a calcium-mobilizing α(1)-adrenergic agonist, phenylephrine. The animal model of monosodium L-glutamate (MSG)-induced obesity was used. The adult rats develop obesity and steatosis. Calcium fluxes were evaluated through measuring the (45)Ca(2+) uptake by liver microsomes, inside-out plasma membrane, and mitochondria. In the liver, assessments were performed on the calcium-dependent glycogenolytic response to phenylephrine and the glycogen contents. The Ca(2+) uptake by microsomes and plasma membrane vesicles was reduced in livers from obese rats as a result of reduction in the Ca(2+)-ATPase activities. In addition, the plasma membrane Na(+)/K(+)-ATPase was reduced. All these matched effects could contribute to elevated resting intracellular calcium levels in the hepatocytes. Livers from obese rats, albeit smaller and with similar glycogen contents to those of control rats, released higher amounts of glucose in response to phenylephrine infusion, which corroborates these observations. Mitochondria from obese rats exhibited a higher capacity of retaining calcium, a phenomenon that could be attributed to a minor susceptibility of the mitochondrial permeability transition pore opening.
本研究旨在探讨脂肪肝堆积是否会影响细胞内钙离子流和肝糖原分解对钙离子动员的α(1)-肾上腺素能激动剂苯肾上腺素的反应。采用单谷氨酸钠(MSG)诱导肥胖的动物模型。成年大鼠发生肥胖和脂肪变性。通过测量肝微粒体、胞浆面膜和线粒体中(45)Ca(2+)摄取来评估钙离子流。在肝脏中,评估了苯肾上腺素诱导的钙离子依赖性糖原分解反应和糖原含量。肥胖大鼠肝脏中微粒体和胞浆面膜囊泡摄取的 Ca(2+)减少,这是由于 Ca(2+)-ATP 酶活性降低所致。此外,质膜 Na(+)/K(+)-ATP 酶也减少。所有这些匹配的效应都可能导致肝细胞内静息钙离子水平升高。肥胖大鼠的肝脏尽管较小,糖原含量与对照组相似,但对苯肾上腺素输注的反应释放出更多的葡萄糖,这证实了这些观察结果。肥胖大鼠的线粒体具有更高的钙保留能力,这种现象可能归因于线粒体通透性转换孔开放的较小易感性。